DK3128014T3 - Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger - Google Patents

Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger Download PDF

Info

Publication number
DK3128014T3
DK3128014T3 DK16176458.4T DK16176458T DK3128014T3 DK 3128014 T3 DK3128014 T3 DK 3128014T3 DK 16176458 T DK16176458 T DK 16176458T DK 3128014 T3 DK3128014 T3 DK 3128014T3
Authority
DK
Denmark
Prior art keywords
biofunctional
sterilizing
compositions
methods
sterilizing biofunctional
Prior art date
Application number
DK16176458.4T
Other languages
English (en)
Inventor
Jens Altrichter
Anja Breuer
Nicole Schaath
Julia Quathamer
Original Assignee
Leukocare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leukocare Ag filed Critical Leukocare Ag
Application granted granted Critical
Publication of DK3128014T3 publication Critical patent/DK3128014T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22Testing for sterility conditions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicinal Preparation (AREA)
DK16176458.4T 2009-03-31 2010-03-31 Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger DK3128014T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09004735A EP2236617A1 (en) 2009-03-31 2009-03-31 Methods of terminal sterilization of biofunctional compositions
EP10712939.7A EP2414538B1 (en) 2009-03-31 2010-03-31 Means and methods of sterilization of biofunctional compositions

Publications (1)

Publication Number Publication Date
DK3128014T3 true DK3128014T3 (da) 2020-02-17

Family

ID=41119898

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16176458.4T DK3128014T3 (da) 2009-03-31 2010-03-31 Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger

Country Status (7)

Country Link
US (3) US8685459B2 (da)
EP (3) EP2236617A1 (da)
JP (2) JP6250281B2 (da)
CN (1) CN102449162B (da)
DK (1) DK3128014T3 (da)
ES (1) ES2770086T3 (da)
WO (1) WO2010112576A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
EP2236617A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
JP2014522827A (ja) * 2011-06-28 2014-09-08 ロイコケア・アクチェンゲゼルシャフト (ポリ)ペプチドのアンフォールディングを防止し、および/または(ポリ)ペプチドの(リ)フォールディングを誘導するための方法
JP6417217B2 (ja) 2011-06-28 2018-10-31 ロイコケア・アクチェンゲゼルシャフト ウイルスまたは細菌の新規な安定化方法
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
CN103446600B (zh) * 2012-05-31 2020-05-22 通用电气公司 为含有葡萄糖氧化酶的膜杀菌的方法和相应的生物传感器
JP6370792B2 (ja) * 2012-10-03 2018-08-08 ツェー・エス・エル・ベーリング・アクチエンゲゼルシャフト タンパク質の精製方法
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
CN103028124B (zh) * 2012-12-21 2014-07-23 菱花集团有限公司 谷氨酸发酵中连实消相结合的物料灭菌方法
WO2014137903A2 (en) 2013-03-08 2014-09-12 Genzyme Corporation Integrated continuous manufacturing of therapeutic protein drug substances
ES2502666B1 (es) * 2013-04-02 2015-10-27 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de estabilización de biomoléculas
TWI671312B (zh) 2014-01-17 2019-09-11 美商健臻公司 無菌層析法及製法
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
JP6951243B2 (ja) * 2015-03-12 2021-10-20 三洋化成工業株式会社 タンパク質組成物の製造方法及びタンパク質組成物
CN105497925B (zh) * 2015-12-25 2019-02-26 烟台正海生物科技股份有限公司 一种在电离辐射灭菌前对功能蛋白进行保护的方法及其专用保护剂
US20190256551A1 (en) 2016-09-16 2019-08-22 Leukocare Ag A novel method of producing a liquid biopharmaceutical drug product
WO2018050870A1 (en) 2016-09-16 2018-03-22 Leukocare Ag A novel method for stabilization of a biopharmaceutical drug product during processing
WO2018050873A1 (en) 2016-09-16 2018-03-22 Leukocare Ag A novel method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation
WO2019217954A1 (en) * 2018-05-11 2019-11-14 North Carolina State University Bioresponsive hydrogel matrixes and methods of use
US11369703B2 (en) 2018-08-31 2022-06-28 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
KR20210132054A (ko) * 2019-01-31 2021-11-03 셀 메디신 가부시키가이샤 무기 염류 단백 복합 의료 기기
CN110665478B (zh) * 2019-09-06 2022-08-23 武汉瑞法医疗器械有限公司 一种用于稳定吸附剂吸附性能的填充液及其应用
CN110935043B (zh) * 2019-12-19 2021-01-12 浙江相伴乳胶制品有限公司 一种乳胶制品的灭菌方法
CN112107720A (zh) * 2020-09-18 2020-12-22 华熙生物科技股份有限公司 透气性好的医用压敏胶及依克多因在提高医用压敏胶透气性中的应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3051627A (en) * 1960-08-18 1962-08-28 Armour Pharma Stabilized chymotrypsin solution
US3957049A (en) * 1973-10-09 1976-05-18 Neefe Charles W Rechargeable drug delivery method
US4121588A (en) * 1977-05-16 1978-10-24 Becton, Dickinson And Company Disposable hypodermic syringe and method of manufacture
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
CA1144849A (en) * 1979-10-24 1983-04-19 Brown (Albert) Limited Sterilisation indicators
JPS60120823A (ja) * 1983-12-02 1985-06-28 Green Cross Corp:The IgG単量体
ATE298561T1 (de) * 1993-04-22 2005-07-15 Emisphere Tech Inc Orale dareichungsform
US5730933A (en) 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
JP3624543B2 (ja) * 1996-05-02 2005-03-02 東ソー株式会社 免疫反応試薬及びその製造方法
US6632648B1 (en) 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
GR1002706B (el) * 1996-05-22 1997-05-26 Μικρογαλακτωματα λεκιθινης περιεχοντα πρωτεολυτικα ενζυμα α-χυμοθρυψινης η θρυψινη και μεθοδος μονιμης ενζυμικης αποτριχωσης.
JP4359352B2 (ja) * 1997-10-23 2009-11-04 田辺三菱製薬株式会社 室温保存製剤
US6140127A (en) * 1998-02-18 2000-10-31 Cordis Corporation Method of coating an intravascular stent with an endothelial cell adhesive five amino acid peptide
ATE327765T1 (de) 1999-08-17 2006-06-15 Glaxosmithkline Biolog Sa Methoden um rotavirusvarianten zu trennen und lebender attenuierter rotavirus impfstoff
US6471979B2 (en) * 1999-12-29 2002-10-29 Estrogen Vascular Technology, Llc Apparatus and method for delivering compounds to a living organism
EP1299131A4 (en) * 2000-03-23 2003-06-18 Clearant Inc METHOD FOR STERILIZING BIOLOGICAL MATERIALS
US20030012687A1 (en) * 2000-03-23 2003-01-16 Macphee Martin J. Methods of sterilizing biological materials
DE60115433T2 (de) * 2000-05-31 2006-08-03 Encelle, Inc. Verfahren zur behandlung von chronischen geschwüren
MXPA03008975A (es) * 2001-04-03 2004-02-17 Bristol Myers Squibb Pharma Co Estabilizacion y esterilizacion terminal de formulaciones de fosfolipidos.
US20030059338A1 (en) * 2001-09-24 2003-03-27 Mann David M. Methods for sterilizing biological materials using flavonoid/flavonol stabilizers
JP2003300908A (ja) * 2002-04-08 2003-10-21 Towa Yakuhin Kk 安定なカルシトニン注射用製剤
WO2004032980A1 (en) * 2002-10-04 2004-04-22 Elan Pharma International Limited Gamma irradiation of solid nanoparticulate active agents
EP1571204B1 (de) * 2004-03-04 2009-11-18 LeukoCare AG Leukozytenstimulations-Matrix
GB0503337D0 (en) 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP2008545461A (ja) * 2005-05-19 2008-12-18 アルバイオレックス, エルエルシー 注射可能コラーゲン生成物の最終滅菌
WO2006130869A1 (en) * 2005-06-02 2006-12-07 Alza Corporation Method for terminal sterilization of transdermal delivery devices
FR2895263B1 (fr) * 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
EP1852443A1 (en) * 2006-05-05 2007-11-07 Leukocare AG Biocompatible three dimensional matrix for the immobilization of biological substances
KR20150138416A (ko) * 2006-07-10 2015-12-09 존슨 앤드 존슨 비젼 케어, 인코포레이티드 약제학적 제제를 함유하는 안과용 렌즈를 위한 패키지
US8747738B2 (en) * 2006-08-15 2014-06-10 Abbott Cardiovascular Systems Inc. Sterilization methods for medical devices
EP2236520A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Stabilizing composition for immobilized biomolecules
EP2236617A1 (en) 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
US8961984B2 (en) * 2009-10-08 2015-02-24 Arch Biophysics, Inc. Surface-coated structures and methods

Also Published As

Publication number Publication date
JP6412477B2 (ja) 2018-10-24
EP2414538A1 (en) 2012-02-08
WO2010112576A1 (en) 2010-10-07
CN102449162A (zh) 2012-05-09
US11564865B2 (en) 2023-01-31
US20120093803A1 (en) 2012-04-19
JP6250281B2 (ja) 2017-12-20
EP2414538B1 (en) 2016-06-29
JP2016028593A (ja) 2016-03-03
EP2236617A1 (en) 2010-10-06
US20230225939A1 (en) 2023-07-20
US20140134214A1 (en) 2014-05-15
EP3128014B1 (en) 2019-11-13
CN102449162B (zh) 2014-08-13
US8685459B2 (en) 2014-04-01
ES2770086T3 (es) 2020-06-30
EP3128014A1 (en) 2017-02-08
JP2012521776A (ja) 2012-09-20

Similar Documents

Publication Publication Date Title
DK3128014T3 (da) Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger
DK3795573T3 (da) Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf
DK2323638T3 (da) Sammensætninger og fremgangsmåder til behandling af osteoartritis
DK2470656T3 (da) Sammensætning til hæmning af genekspression og anvendelser heraf
DK2419732T3 (da) Prionfrie nanopartikelsammensætninger og fremgangsmåder
DK2504353T4 (da) Lipopeptidsammensætninger og tilsvarende fremgangsmåder
FR2947716B1 (fr) Implant prothetique ameliore
DK2361090T3 (da) Sammensætninger til behandling af centralt medieret kvalme og opkastning
DK2270818T3 (da) Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten
DK2316382T3 (da) Protese til ucementeret fiksering
DK2446246T3 (da) Indretning og fremgangsmåde til udvælgelse af partikler
DK2398902T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af cancer
DK2496562T3 (da) Fremgangsmåde til fremstilling af calcobutrol
DK3260118T3 (da) Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
DK2309938T3 (da) Kryokirurgiske systemer og fremgangsmåder til anvendelse heraf
DK3444613T3 (da) Fremgangsmåder til diagnosticering og behandling af autisme
DK3284820T3 (da) Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
DK2415349T3 (da) Fremgangsmåde til fremstilling af afsaltet mælk, og afsaltet mælk
DK2456544T3 (da) Fremgangsmåde til fjernelse af gasformig væske og indretning dertil
DK2482841T4 (da) Sammensætninger og fremgangsmåder til at forbedre koagulationsfaktor-viii-funktion
DK2552484T3 (da) Fremgangsmåder og sammensætninger til reducering af parathyroidniveauer
DK2499454T3 (da) System og fremgangsmåde til måling af bane
FI20096351A0 (fi) Implanttijärjestelmä
DK3078739T3 (da) Sammensætning og fremgangsmåde til muliggørelse af proliferation af pluripotente stamceller
DK2320739T3 (da) Farmaceutiske sammensætninger og fremgangsmåder til stabilisering af disse